Larimar Therapeutics Stock (NASDAQ: LRMR) stock price, news, charts, stock research, profile.
You can purchase shares of Larimar Therapeutics (NASDAQ:LRMR) through any online brokerage.
Other companies in Larimar Therapeutics’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Sage Therapeutics (NASDAQ:SAGE) and Tango Therapeutics (NASDAQ:TNGX).
Larimar Therapeutics has a consensus price target of $19.00.
The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $6.4597 last updated November 25, 2024 at 11:06 AM EST.
There are no upcoming dividends for Larimar Therapeutics.
Larimar Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for Larimar Therapeutics.
Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.